Vanda Pharmaceuticals
VNDA
#7861
Rank
A$0.47 B
Marketcap
A$8.11
Share price
3.65%
Change (1 day)
7.30%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : A$0.44 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has A$0.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.60 B5.69%
2023-12-31A$0.56 B-16.93%
2022-12-31A$0.68 B14.92%
2021-12-31A$0.59 B24.83%
2020-12-31A$0.47 B7.28%
2019-12-31A$0.44 B22.03%
2018-12-31A$0.36 B98.87%
2017-12-31A$0.18 B-6.32%
2016-12-31A$0.19 B-0.24%
2015-12-31A$0.19 B23.9%
2014-12-31A$0.15 B8.55%
2013-12-31A$0.14 B26.13%
2012-12-31A$0.11 B-20.21%
2011-12-31A$0.14 B-25.52%
2010-12-31A$0.19 B-14.69%
2009-12-31A$0.22 B247.05%
2008-12-31A$65.84 M-32.41%
2007-12-31A$97.42 M140.96%
2006-12-31A$40.42 M-5.04%
2005-12-31A$42.57 M102.64%
2004-12-31A$21.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
A$14.68 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$14.92 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.94 B 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$24.84 B 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$22.55 B 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
A$4.21 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$27.42 B 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA